ADD-ASPIRIN: A Phase III, Double-Blind, Placebo Controlled, Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non-Metastatic Solid Tumours

Contemporary Clinical Trials - Netherlands

doi 10.1016/j.cct.2016.10.004